International Journal of Trichology International Journal of Trichology
 Print this page Email this page Small font sizeDefault font sizeIncrease font size
 
 
  Home | About IJT | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submission | Subscribe | Advertise | Contact us | Login   
 

    Article Cited by others

ORIGINAL ARTICLE

Topical Melatonin for Treatment of Androgenetic Alopecia

Fischer Tobias W, Trüeb Ralph M, Hänggi Gabriella, Innocenti Marcello, Elsner Peter

Year : 2012| Volume: 4| Issue : 4 | Page no: 236-245

   This article has been cited by
 
1 Clinical Patterns of Hair Loss in Men
Natalie Kash, Matt Leavitt, Adam Leavitt, Spencer D. Hawkins, Rahil B. Roopani
Dermatologic Clinics. 2021; 39(3): 361
[Pubmed]  [Google Scholar] [DOI]
2 The ‘bald’ phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral ‘western diet’
Nicholas John Sadgrove
Trends in Food Science & Technology. 2021; 116: 1170
[Pubmed]  [Google Scholar] [DOI]
3 Redirecting drug repositioning to discover innovative cosmeceuticals
Georgia Sotiropoulou, Eleni Zingkou, Georgios Pampalakis
Experimental Dermatology. 2021; 30(5): 628
[Pubmed]  [Google Scholar] [DOI]
4 Managing patterned hair loss – a hair raising task!
Aseem Sharma, Manasi Shirolikar, Madhulika Mhatre
Cosmoderma. 2021; 1: 55
[Pubmed]  [Google Scholar] [DOI]
5 ANDROGENETIK ALOPESI
Gökhan SAHIN, Hilal ÖZDEMIR, Fatma AYDIN
Uludag Üniversitesi Tip Fakültesi Dergisi. 2021;
[Pubmed]  [Google Scholar] [DOI]
6 Melatonin as an Antioxidant and Immunomodulator in Atopic Dermatitis—A New Look on an Old Story: A Review
Andrzej Kazimierz Jaworek, Jacek Cezary Szepietowski, Przemyslaw Halubiec, Anna Wojas-Pelc, Jolanta Jaworek
Antioxidants. 2021; 10(8): 1179
[Pubmed]  [Google Scholar] [DOI]
7 Valproate-associated hair abnormalities: Pathophysiology and management strategies
Samir Kumar Praharaj, Ravindra N. Munoli, Suma T. Udupa, Sivapriya Vaidyanathan
Human Psychopharmacology: Clinical and Experimental. 2021;
[Pubmed]  [Google Scholar] [DOI]
8 A Scoping Review of Pharmacotherapy, Complementary, and Alternative Medicine (CAM), and Surgical Therapies for Androgenic Alopecia
Colby L. Presley, Tesia C. Kolodziejczyk, Kayd J. Pulsipher, Jalal Maghfour, Michelle Militello, Hope R. Rietcheck, Allene Fonseca, Temitope J. Olayinka, Chandler W. Rundle, Jacquelyn D. Waller, Robert P. Dellavalle
Current Dermatology Reports. 2021; 10(2): 48
[Pubmed]  [Google Scholar] [DOI]
9 Management of chemotherapy-induced alopecia (CIA): A comprehensive review and future directions
Emaan Haque, Mohamad S. Alabdaljabar, Kathryn J. Ruddy, Tufia C. Haddad, Carrie A. Thompson, Julia S. Lehman, Shahrukh K. Hashmi
Critical Reviews in Oncology/Hematology. 2020; 156: 103093
[Pubmed]  [Google Scholar] [DOI]
10 Hormonal regulation in male androgenetic alopecia—Sex hormones and beyond: Evidence from recent genetic studies
Stefanie Heilmann-Heimbach, Lara M. Hochfeld, Sabrina K. Henne, Markus M. Nöthen
Experimental Dermatology. 2020; 29(9): 814
[Pubmed]  [Google Scholar] [DOI]
11 Current and emerging treatments targeting the neuroendocrine system for disorders of the skin and its appendages
Michael Soeberdt, Ana Kilic, Christoph Abels
Experimental Dermatology. 2020; 29(9): 801
[Pubmed]  [Google Scholar] [DOI]
12 Androgenetic Alopecia: An Evidence-Based Treatment Update
Supenya Varothai,Wilma F. Bergfeld
American Journal of Clinical Dermatology. 2014;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article